Security That Matches the Sensitivity of Your Data. Real Security Testing for Biotech, Genomics & Digital Health Platforms
We start with real security — and build compliance into every step. Our deep-dive, threat-modeled testing uncovers risks that matter, with reports aligned to HIPAA, FDA, and MDR requirements
HIPAA, FDA, and MDR-aligned
Threat-modeled
Audit-ready
What we test
Who do we work with?
Data Marketplaces & Clinical Trial Recruitment Platforms
Direct-to-Consumer Testing kits companies
Diagnostics-as-a-Service
Risks we protect you from
Biotech platforms carry some of the most sensitive, high-stakes data in the world — but most security testing doesn’t go deep enough. Weak authentication, feature-abuse, cloud misconfigurations, and architecture-level flaws often go untested — leaving systems exposed in ways compliance checks never reveal.
The 23andMe, Enzo Biochem, and Cencora breaches made it clear: attackers don’t care about compliance — they exploit real gaps in how platforms are built and secured.
Data breaches are escalating in biotech — and regulators are paying attention. Weak MFA, exposed APIs, and untested architectures cost companies their trust, users, and funding.
Leaked DNA or health data is irreversible
Compliance doesn’t equal security
Breach of trust is hard to repair
Partnerships and funding are put at risk
Security failures lead to lawsuits, fines, and lost funding
What we offer?
Sekurno delivers in-depth pentesting for biotech companies — tailored to how attackers actually think, not just what auditors check
Threat modeling + OWASP testing Report
Aligned with HIPAA, FDA, MDR
Submission-ready reports
Performed by senior
offensive security experts
Methodologies
True to our commitment, we don't merely reference methodologies like OWASP and PTES — we embody them.
After thorough testing, we conclude with a detailed checklist, ensuring transparent and genuine adherence to these recognized standards.
Penetration Testing Execution Standard
Application Security Verification Standard
Web Security Testing Guide
Mobile Security Testing Guide
Approach
What’s included
Grounded in real-world breaches in the biotech industry and tailored to the risks that matter most — from leaked DNA data to flawed auth flows. We understand that in this space, there’s no room for mediocrity — every component must be tested with precision and context
Threat modeling aligned to your actual data flows and architecture
Whitebox approach for full-context testing (finds ~30% more critical issues)
Verification of 130+ OWASP controls across web applications
All available detection methods: manual testing, code review, SAST, DAST, SCA, secret scanning
Leaked credentials check across darkweb sources and breach databases
Security engineers are incentivized to go deeper — our bonus pool rewards real findings
All reports and deliverables are aligned with HIPAA, FDA, and MDR requirements
Self-Assessment checklists
What our clients are saying
90% of our clients return
Sekurno exceeded our expectations, identifying critical vulnerabilities that neither we nor other vendors had detected, and providing actionable recommendations. Their team was responsive, flexible, and consistently provided valuable insights.
Sep 18, 2024
Markus T.
Chief Technology Architect
If you are going to invest in penetration testing, make sure it is more than just a formality. Work with a partner who helps you learn something from the process and improves your actual security. With Sekurno, we received useful feedback and our team became more security aware as a result.
April 11, 2025
Mads
CTO
Our collaboration with Sekurno has consistently been seamless.
Jun 12, 2023
Roy
DG VP
We were genuinely impressed; Sekurno identified vulnerabilities that even major cybersecurity companies within the Google group missed
April 11, 2025
Chan S.
CEO
Their expertise was evident in every aspect of the engagement.
Sep 18, 2024
Max, R.
Deputy CTO
